These findings suggest that PINK1 plays a crucial role in modulating mitochondrial dynamics that confer therapeutic resistance, highlighting its potential as a therapeutic target for overcoming olaparib resistance in prostate cancer. The gene discussed is PINK1; the disease is prostate cancer.